Market
Scenario
Acromegaly is a chronic
metabolic disorder caused by excess secretion of growth hormone (GH) by the
pituitary gland. The excess secretion of
GH results in gradual enlargement of body tissues including the bones of the
face, jaw, hands, feet, and skull. Acromegaly is a rare disease, which is the
most often diagnosed in the middle-aged adults and affects 5-8 people per 1
lakh people. If the diseases remains untreated, it may cause serious illness
and premature death. The market is experiencing rapid growth owing to
increasing prevalence of acromegaly, changing lifestyle and increasing need for
better treatment & cost-effective treatment. Additionally, increasing
government support along with the per capita income fuels the market growth.
However, the cost of the treatment ranges from USD 2,800 to USD 9,200. On the
other hand, the market may witness slow growth over the assessment period due
to high cost of treatment and limited number of treatment.
The
global acromegaly market is expected to grow
at a CAGR of ~5.2 % during the forecast period 2017-2023.
Regional
Analysis
The Americas commands the global market owing to
increasing prevalence of acromegaly, large patient population, high healthcare
spending, and strong government support for research & development.
According to the Health Research Funding Organization, in America, over 3,000
new cases of acromegaly occurs per year.
Europe leads the second position of the global the
market, which is followed by Asia Pacific. High healthcare expenditure, well
developed healthcare sector, and increasing government support drives the
growth of the market.
Asia Pacific is the fastest growing acromegaly
market. China, and India are the significant contributors to the market growth
due to the presence of huge population base, increasing prevalence of
acromegaly, rapidly growing healthcare sector, and increasing healthcare
expenditure. Whereas, the Middle East & Africa holds the least share of the
global market due to poor economic condition and limited availability of
medical facilities in African region. The Middle East & African acromegaly
market is majorly driven by the UAE, Saudi Arabia, and Kuwait.
Segmentation
Acromegaly market is segmented on the basis of
type, diagnosis, treatment, and end user.
On the basis of type, the market is segmented into
ectopic acromegaly, acromegaly due to growth hormone, and others.
On the basis of diagnosis, the market is segmented
into medical imaging, medical laboratory investigations, others. The medical imaging
is further segmented into radiography, magnetic resonance imaging (MRI),
nuclear medicine, ultrasound, and others.
On the basis of treatment, the market is segmented
into medications, surgery, radiation therapy, and others. The medication is
further segmented into somatostatin analogues, dopamine agonists, growth
hormone receptor antagonists, and others. The surgery is further segmented into
endonasal transphenoidal surgery, and transphenoidal surgery.
Key
Players
Some of
key the players in the market are Novartis AG (Switzerland), Aegis Therapeutics
LLC (US), Chiasma Inc (US), Crinetics Pharmaceuticals Inc (US), Daewoong
Pharmaceutical Co Ltd (South Korea), Peptron Inc (South Korea), Silence
Therapeutics Plc (UK), Strongbridge Biopharma plc (US), Amryt Pharma plc (UK),
Foresee Pharmaceuticals LLC (US), Glide Pharmaceutical Technologies Ltd (US),
Ionis Pharmaceuticals Inc (US), Ipsen SA (France)
Detailed Table
of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1
Definition
2.2
Scope Of The Study
2.2.1
Research Objective
2.2.2 Assumptions
2.2.3
Limitations
Chapter 3. Research Methodology
3.1
Introduction
3.2
Primary Research
3.3
Secondary Research
3.4
Market Size Estimation
...Continued
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment